Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans

Journal of Nuclear Medicine

Volumn 46, Issue 4, 2005, Pages 614-619

  Parsey, Ramin V ^a,b,d   Belanger, Marie Jose ^a,b   Sullivan, Gregory M ^a,b   Simpson, Norman R ^a,b   Stabin, Michael G ^c   Van Heertum, Ronald ^a,b   Mann, J John ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d Box 42 ^*  (United States)

Author keywords

PET; Serotonin; Serotonin 1A

Indexed keywords

AMIDE; CARBON 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRINIDYL) CYCLOHEXANE CARBOXAMIDE; SEROTONIN 1A ANTAGONIST; UNCLASSIFIED DRUG; WAY 100 635; DIAGNOSTIC AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; WHOLE BODY SCINTISCANNING; BLADDER; BODY BURDEN; CLINICAL TRIAL; KIDNEY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; RADIOMETRY; RELATIVE BIOLOGIC EFFECTIVENESS; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; WHOLE BODY COUNTING;

ADULT; BODY BURDEN; FEMALE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; PIPERAZINES; PYRIDINES; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RELATIVE BIOLOGICAL EFFECTIVENESS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; URINARY BLADDER; WHOLE-BODY COUNTING;

EID: 19644391612     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pike VW, McCarron JA, Lammertsma AA, et al. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol. 1996;301:R5-R7.
2. 11C]WAY-100635 binding to 5-HT1A receptors in the primate brain. Psychopharmacology (Berl). 1997;133:196-202.
3. Drevets WC, Frank E, Price JC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375-1387.
4. 11C]WAY- 100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab. 2000;20:1111-1133.
5. 11C]WAY 100635 i 5-HT1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse. 2001;41:150-159.
6. Passchier J, van Waarde A. Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur J Nucl Med Mol Imaging. 2001;28:113-129.
7. Tauscher J, Bagby RM, Javanmard M, et al. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry. 2001;158:1326-1328.
8. Tsukada H, Kakiuchi T, Nishiyama S, et al. Effects of aging on 5-HT(1A) receptors and their functional response to 5-HT(1a) agonist in the living brain: PET study with [carbonyl-(11)C]WAY-100635 in conscious monkeys. Synapse. 2001;42:242-251.
9. Parsey RV, Oquendo MA, Simpson NR, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT(1A) receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 2002;954:173-182.
10. Rabiner EA, Messa C, Sargent PA, et al. A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage. 2002;15:620-632.
11. Borg J, Andree B, Soderstrom H, et al. The serotonin system and spiritual experiences. Am J Psychiatry. 2003;160:1965-1969.
12. 11C]WAY-100635. Arch Gen Psychiatry. 2002;59:514-520.
13. Neumeister A, Bain E, Nugent AC, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24:589-591.
14. Michel C, Sibomana M, Bol A. Preserving Poisson characteristics of PET data with weighted OSEM reconstruction. IEEE Trans Med Imaging. 1999;2:1323-1329.
15. Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amns J-L, eds. Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1996:255-268.
16. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculation. Reston, VA: Society of Nuclear Medicine; 1991.
17. Press W, Flannery B, Teukolsky S, et al. Numerical Recipes in C: The Art of Scientific Computing. Cambridge, U.K.: Cambridge University Press; 1989.
18. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538-546.
19. 11C-DASB determined from human whole-body PET. J Nucl Med. 2004;45:1555-1559.
20. 11C]mirtazapine, an antidepressant affecting adrenoceptors. Appl Radiat Isot. 2003;59:175-179.
21. 18F-FECNT in non-human primates. Nucl Med Commun. 2004;25:737-742.